Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The changing face of HIV vaccine research.

Journal of the International AIDS Society - 5 Jul 2012

Kwong Peter D, Mascola John R, Nabel Gary J

Abstract excerpt

While there has been remarkable progress in understanding the biology of HIV-1 and its recognition by the human immune system, we have not yet developed an efficacious HIV-1 vaccine. Vaccine challenges include the genetic diversity and mutability of HIV-1 which create a plethora of constantly changing antigens, the structural features of the viral envelope glycoprotein that disguise conserved receptor-binding...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AIDS Vaccines
Share to Antibodies, Neutralizing
Share to Antigens, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials as Topic

Share to Drug Discovery

Share to HIV Antibodies

Share to HIV Infections

Source

Open in PubMed Open full text

Identifiers

PMID: 22789610
DOI: 10.7448/IAS.15.2.17407
PMCID: PMC3499796

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The changing face of HIV vaccine research.PMID 22789610Read ↗

The challenges of host and viral diversity in HIV vaccine design.Semantic proximity Read ↗

The HIV-1 vaccine race.Semantic proximity Read ↗

Challenges in the design of a T cell vaccine in the context of HIV-1 diversity.Semantic proximity Read ↗

Translational research insights from completed HIV vaccine efficacy trials.Semantic proximity Read ↗

Harnessing the protective potential of HIV-1 neutralizing antibodiesSemantic proximity Read ↗

HIV-1 vaccine design: harnessing diverse lymphocytes to conquer a diverse pathogen.Semantic proximity Read ↗

HIV-1 vaccine immunogen design strategiesSemantic proximity Read ↗

A Remarkable Genetic Shift in a Transmitted/Founder Virus Broadens Antibody Responses Against HIV-1Semantic proximity Read ↗

Targeting HIV-1 conserved regions: An immunoinformatic pathway to vaccine innovation for the AsiaSemantic proximity Read ↗

Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1Semantic proximity Read ↗

Vaccines and immunology: elucidating immunity to HIV-1 and current prospects for AIDS vaccine development.Semantic proximity Read ↗

<scp>HIV</scp>‐1 neutralizing antibodies: understanding nature's pathwaysSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.